← Eichor
Study identifier: NCT05771168 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Surgery for Male Stress Urinary Incontinence

Condition: Male Stress Urinary Incontinence  ·  Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

PhaseN/A
Planned participants138
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this observational prospective study is to evaluate the success rate (cure plus improvement) of procedures for treatment of male stress urinary incontinence (artificial urinary sphincter or male slings) at 5 years of study follow-up and to determine other outcomes of surgical treatment for each of the devices and, to perform a prognostic factor analysis to identify clinical and surgical variables that correlate with (in)continence or revisions for each of the device subtypes. Cure is defined as urinary continence with no need for use of pads or the use of 1 light security pad; the improvement is defined as the reduction of≥ 50% of the number of pads with use of no more than two pads.

This description comes directly from the study's public registry record.

Talk to the study team

Emilio Sacco, Professor  ·  +390630155290  ·  emilio.sacco@policlinicogemelli.it

Always discuss trial participation with your own doctor first.

Locations (1)

Università Cattolica del Sacro Cuore, Fondazione Policlinico Agostino GemelliRoma, Rome, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05771168